AbCellera Biologics Inc. (ABCL) has a market capitalization of $1.14B and trades at $3.76. The 52-week range is 1.891-6.515.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.7, Earnings Per Share (EPS) of $-0.49, annual revenue of $75.13M.
The stock has a beta of 0.85, operates in the Healthcare sector.
